Fundraising FoxClear Current Capital — 2024 Investments
5 investments dated 2024 · listed companies and verified rows first · show all
Boston Bioprocess provides fermentation and bioprocess development services—including scale-up across 1.5L to 1,500L vessels, downstream process development, regulatory guidance, and tech transfer to CMOs—for companies bringing biomanufactured products to production.
AI & Machine LearningBiotechSaaSChampaign, US
Michael Tai(Executive Officer, Director)Ted Netland(Executive Officer, Director)
BoardJames Caffyn(Director)in
Co-investorsFTW VenturesLever VCSiddhi Capital
Brightly provides AI-powered measurement and carbon credit solutions for food waste reduction and recovery organizations.
AI & Machine LearningCleantechClimate TechFoodTechImpact & Social Good
Andy Levitt(Founder & CEO)in
Co-investorsCollaborative FundG-ForceTacoma Venture Fund
Brightly was a company oriented around sustainability that has ceased operations, as indicated by a farewell message on its site.
Climate TechImpact & Social Good
Laura Alexander Wittig(Founder)in
Co-investorsigniteXL VentureCollaborative FundG-ForceTacoma Venture Fund
Nosh develops food ingredients made from fungal fermentation as a sustainable alternative to animal-derived products, aiming to deliver taste, texture, nutrition and affordability.
BiotechClimate TechFoodTechNew MaterialsBerlin, DE
Felipe Lino(Founder)in
Co-investorsCheck24 VenturesEarlybird Venture CapitalGrey Silo VenturesKickstart Innovation
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Sunflower Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.